Final results of the phase 3 VISTA trial: bortezomib-melphalan-prednisone (VMP) vs melphalan-prednisone (MP) for multiple myeloma Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain 14 Dec 2011